Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Aug-23 4:06 PM View:  | Merrimack Pharmaceuticals, ... (MACK) | 11-Aug-23 | Purchase | 2,000 | $12.43 | $24,865.20 | 2% 131.1K to 133.1K | |
| 14-Aug-23 4:06 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 10-Aug-23 | Purchase | 2,000 | $12.52 | $25,039.20 | 2% 131.1K to 133.1K | |
| 13-Jun-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 09-Jun-22 | Purchase | 4,452 | $5.15 | $22,918.00 | 4% 126.65K to 131.1K | |
| 09-Jun-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 08-Jun-22 | Purchase | 349 | $5.14 | $1,795.12 | < 1% 126.3K to 126.65K | |
| 09-Jun-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 07-Jun-22 | Purchase | 300 | $5.05 | $1,515.00 | < 1% 126.0K to 126.3K | |
| 26-May-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 25-May-22 | Purchase | 132 | $5.13 | $677.79 | < 1% 125.87K to 126.0K | |
| 26-May-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 24-May-22 | Purchase | 2,323 | $5.09 | $11,816.90 | 2% 123.55K to 125.87K | |
| 23-May-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 19-May-22 | Purchase | 512 | $5.04 | $2,581.91 | < 1% 123.04K to 123.55K | |
| 19-May-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 18-May-22 | Purchase | 5,000 | $5.08 | $25,407.00 | 4% 118.04K to 123.04K | |
| 19-May-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 17-May-22 | Purchase | 225 | $5.10 | $1,146.51 | < 1% 117.81K to 118.04K | |
| 16-May-22 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-May-22 | Purchase | 3 | $4.90 | $14.70 | < 1% 117.81K to 117.81K | |
| 16-May-22 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-May-22 | Purchase | 2,471 | $5.04 | $12,456.10 | 2% 115.34K to 117.81K | |
| 25-Apr-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 21-Apr-22 | Purchase | 5,000 | $6.00 | $30,001.00 | 5% 110.34K to 115.34K | |
| 01-Apr-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 31-Mar-22 | Purchase | 300 | $6.18 | $1,853.01 | < 1% 110.04K to 110.34K | |
| 01-Apr-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 30-Mar-22 | Purchase | 161 | $6.20 | $998.20 | < 1% 109.88K to 110.04K | |
| 29-Mar-22 5:30 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 28-Mar-22 | Purchase | 5,000 | $6.16 | $30,821.50 | 5% 104.88K to 109.88K | |
| 24-Mar-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 22-Mar-22 | Purchase | 400 | $6.11 | $2,445.52 | < 1% 104.48K to 104.88K | |
| 17-Mar-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 15-Mar-22 | Purchase | 4,649 | $6.14 | $28,555.60 | 5% 99.83K to 104.48K | |
| 15-Mar-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 14-Mar-22 | Purchase | 5,000 | $6.02 | $30,120.50 | 5% 94.83K to 99.83K | |
| 15-Mar-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 11-Mar-22 | Purchase | 5,000 | $6.08 | $30,406.50 | 6% 89.83K to 94.83K | |
| 23-Feb-22 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 18-Feb-22 | Purchase | 3,351 | $5.96 | $19,969.60 | 4% 86.48K to 89.83K | |
| 18-Feb-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 17-Feb-22 | Purchase | 5,000 | $6.13 | $30,626.00 | 6% 81.48K to 86.48K | |
| 18-Feb-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 16-Feb-22 | Purchase | 7,945 | $6.20 | $49,231.20 | 11% 73.53K to 81.48K | |
| 16-Feb-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 15-Feb-22 | Purchase | 123 | $6.20 | $762.60 | < 1% 73.41K to 73.53K | |
| 16-Feb-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 14-Feb-22 | Purchase | 1,800 | $5.96 | $10,723.70 | 3% 71.61K to 73.41K | |
| 31-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 27-Jan-22 | Purchase | 673 | $4.60 | $3,095.80 | < 1% 70.94K to 71.61K | |
| 27-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 26-Jan-22 | Purchase | 3,100 | $4.56 | $14,121.10 | 5% 67.84K to 70.94K | |
| 25-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 24-Jan-22 | Purchase | 7,105 | $4.33 | $30,741.20 | 12% 60.73K to 67.84K | |
| 25-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 21-Jan-22 | Purchase | 2,000 | $4.65 | $9,309.60 | 3% 58.73K to 60.73K | |
| 20-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 18-Jan-22 | Purchase | 5,000 | $4.54 | $22,689.50 | 9% 53.73K to 58.73K | |
| 18-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 14-Jan-22 | Purchase | 5,000 | $4.51 | $22,553.50 | 10% 48.73K to 53.73K | |
| 18-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-Jan-22 | Purchase | 5,000 | $4.42 | $22,120.50 | 11% 43.73K to 48.73K | |
| 13-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Jan-22 | Purchase | 5,000 | $4.33 | $21,658.00 | 13% 38.73K to 43.73K | |
| 13-Jan-22 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 11-Jan-22 | Market Purchase | 5,000 | $4.03 | $20,140.50 | 15% 33.73K to 38.73K | (6%) |
| 14-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Apr-21 | Market Purchase | 973 | $6.07 | $5,905.14 | 3% 32.76K to 33.73K | 5% |
| 12-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 09-Apr-21 | Market Purchase | 1,200 | $6.10 | $7,320.00 | 4% 31.56K to 32.76K | 4% |
| 09-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 07-Apr-21 | Market Purchase | 2,127 | $6.19 | $13,166.10 | 7% 29.43K to 31.56K | 3% |
| 01-Apr-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 31-Mar-21 | Market Purchase | 500 | $6.19 | $3,094.50 | 2% 28.93K to 29.43K | 3% |
| 26-Mar-21 5:46 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 25-Mar-21 | Market Purchase | 200 | $6.13 | $1,226.00 | < 1% 28.73K to 28.93K | 4% |
| 25-Mar-21 5:50 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 24-Mar-21 | Market Purchase | 5,000 | $6.34 | $31,690.00 | 21% 23.73K to 28.73K | < 1% |
| 25-Mar-21 5:50 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 23-Mar-21 | Market Purchase | 3,627 | $6.47 | $23,454.70 | 18% 20.1K to 23.73K | (2%) |
| 17-Mar-21 5:08 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 16-Mar-21 | Market Purchase | 5,000 | $6.79 | $33,956.00 | 33% 15.1K to 20.1K | (6%) |
| 05-Mar-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 23-Feb-21 | Market Purchase | 5,000 | $7.20 | $36,004.50 | 49% 10.1K to 15.1K | (12%) |
| 17-Feb-21 4:05 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 12-Feb-21 | Market Purchase | 5,000 | $7.47 | $37,342.00 | 98% 5.1K to 10.1K | (15%) |
| 12-Feb-21 6:16 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 11-Feb-21 | Market Purchase | 1,604 | $7.98 | $12,797.50 | 46% 3.5K to 5.1K | (20%) |
| 12-Feb-21 6:16 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 10-Feb-21 | Market Purchase | 3,500 | $7.64 | $26,756.80 | 100% 0 to 3.5K | (17%) |
| 24-Jul-20 7:03 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 22-Jul-20 | Market Sale | 117,963 | $3.08 | $362,903.00 | (61%) 193.51K to 75.55K | (107%) |
| 24-Jul-20 7:03 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 22-Jul-20 | Market Sale | 75,546 | $3.09 | $233,562.00 | (100%) 75.55K to 0 | (106%) |
| 10-Apr-15 9:41 AM View: | Merrimack Pharmaceuticals, ... (MACK) | 02-Apr-15 | Option Exercise | 85,000 | $2.16 | $183,350.00 | 3% 2.86M to 2.94M | |
| 14-Nov-14 10:00 PM View: | Merrimack Pharmaceuticals, ... (MACK) | 13-Nov-14 | Market Purchase | 8,630 | $8.37 | $72,233.10 | < 1% 2.85M to 2.86M | (95%) |